Cargando…
FAM83 family oncogenes are broadly involved in human cancers: an integrative multi‐omics approach
The development of novel targeted therapies for cancer treatment requires identification of reliable targets. FAM83 (‘family with sequence similarity 83’) family members A, B, and D were shown recently to have oncogenic potential. However, the overall oncogenic abilities of FAM83 family genes remain...
Autores principales: | Snijders, Antoine M., Lee, Sun‐Young, Hang, Bo, Hao, Wenshan, Bissell, Mina J., Mao, Jian‐Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527452/ https://www.ncbi.nlm.nih.gov/pubmed/28078827 http://dx.doi.org/10.1002/1878-0261.12016 |
Ejemplares similares
-
FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021) -
Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review
por: Jiang, Yi, et al.
Publicado: (2023) -
Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
por: Cipriano, Rocky, et al.
Publicado: (2013) -
FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance
por: Bartel, Courtney A., et al.
Publicado: (2016) -
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)